Counting down the days until #AACR26! 🙌 IDT’s trusted experts are excited to meet you at Danaher booth #4217 to discover how our quality #NGSsolutions power over 80% of the #MRD market. Learn more: https://ow.ly/f6AT50YCq2f#AACR26#4217#NGSsolutions#MRD#AACR2026 #NGS #nextgenerationsequencing

Attention CRISPR Medicine Conference attendees: Catch us on the main stage! Ashley Jacobi will be speaking about how our custom guide RNAs and CRISPR off-target solutions can support you from early research to therapeutic development. Show details: https://event.fourwaves.com/crisprmed26/pages

Boost your edits and fast-track your breakthrough. 🚀 Learn how our Alt-R™ HDR Enhancer Protein improves CRISPR knock-in efficiency by promoting HDR pathway precision—seamlessly integrated into workflows. Full video here: https://idtb.io/8w38y8 Discover what’s possible here: https://idtb.io/fov3yc

This year's symposium is sponsored by @10xgenomics.bsky.social @idtdna.bsky.social If you're here with us at #OxSymp26 today, make sure to visit their stalls during the breaks!

We’re heading to Copenhagen for CRISPR Medicine Conference! Come visit our experts at booth #B1 to discover how our high-quality reagents, design tools, and end-to-end CRISPR workflow solutions have the power to accelerate research and therapeutic progress: https://event.fourwaves.com/crisprmed26

Great to welcome representatives from @idtdna.bsky.social to Macquarie University last week for a tour of our Centre and Australian Genome Foundry. We discussed a variety of ways to engage with synthetic biology at Macquarie. Looking forward to future collaboration. 🤝

ICYMI: We’ve entered the #IVD market! IDT’s latest innovations—Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx—will equip molecular pathologists with compliant in vitro diagnostics, without comprising innovation. Read more: https://idtb.io/4sup2b#IVD #invitrodiagnostics #NGS #molecularpathology

Too complex? Too long? Not a prob. We cover every dimension of DNA complexity—from fast fragments to 50 kb sequence-perfect constructs in partnership with Ansa. Expect fast turnaround, dependable delivery, and sequence-perfect DNA, so your boldest ideas don’t have to wait: idtb.io/07t7jr

IDT has been a driving force in the #MRDresearch market since the earliest days of the field. From sample to sequencer, our end to end capabilities and expertise continue to enable innovation and help shape the future #MRD landscape. Read more from Ajay Gannerkote: www.linkedin.com/pulse/from-s...

We are extremely proud to announce our entry into the NGS in vitro diagnostics (IVD) market. Introducing Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx. These solutions will equip molecular pathologists with compliant in vitro diagnostics, without comprising innovation: https://idtb.io/z38bju

Tune in to The Beat featuring IDT President, Ajay Gannerkote. Understand how precision oncology is leading the way for cancer care, how breakthroughs in #MRDassessment and #MCED are transforming cancer, and how our #NGSsolutions are powering the research behind this progress: https://bit.ly/44yJYV1

We're honored to be a part of the work that earned Danaher the 2026 ASGCT Catalyst Award—recognizing the cross-company collaboration behind the pioneering personalized #geneediting therapy developed for Baby KJ: https://ow.ly/huKr50Ysmmw

Move beyond limitations! When complexity stops others, we keep going. We’ve partnered with @ansabio.bsky.social to provide you with long, complex clonal DNA up to 50 kb. Expect fast turnaround, dependable delivery, and sequence-perfect DNA, so your boldest ideas don’t have to wait: idtb.io/07t7jr

"We can never do enough early collaboration.” 🤝 At #PMWC26, IDT President Ajay Gannerkote shared that early partnership is essential to accelerating innovations in #MRD. The panel explored how breakthroughs in cfDNA and cfRNA profiling are reshaping MRD, and transforming the future of oncology.

We’ve made it to #PMWC26! Attendees—remember to: 👉Stop by booth #B722 to speak with IDT experts about how we’re powering over 80% of the MRD research market. 👉Attend IDT President Ajay Gannerkote’s panel on advancing MRD detection through cfDNA and cfRNA profiling (today, March 4, 11:00 a.m.).

🗣"IDT is investing boldly in the next era of next generation sequencing." ✨ Last week, IDT President Ajay Gannerkote delivered a bronze sponsor talk at #AGBTgm titled "Accelerating enhanced genomic solutions", discussing strategies and real-world insights designed to accelerate discovery.

Just before #RareDiseaseDay, we’re reminded that although rare conditions affect smaller populations, together they represent a large unmet need in global health. Demaris Mills shares how tailored #geneediting therapies could transform care for those affected: www.forbes.com/councils/for...

Ajay Gannerkote will be speaking about advancing #MRD detection through cfDNA and cfRNA profiling at #PMWC26! Join Ajay’s panel to explore how cfDNA and cfRNA profiling are helping to advance MRD detection and reshape the future of cancer care. Learn more: pmwcintl.com/session/mar-...

#AGBTgm is here! Catch Nika Grillmeyer and Konstantin Fiedler as they share their day-one excitement, highlight IDT’s newest innovations, and talk about what they’re looking forward to this week. Visit the Nassau Suite to learn how our NGS portfolio is powering discoveries in cancer research.

#AGBT ATTENDEES! 🥼 Need reasons to stop by Nicholas Downey's and Katelyn Larkin’s poster presentations? We’ve got you covered. Come learn about IDT's new innovations in practice from 1:30-3:30 today, February 24. Look out for posters #419 and #441! #AGBTgm #AGBT26

We've made it to Orlando for #AGBT26! 🤩 We're in the Nassau Suite ready to chat about how our NGS portfolio is powering discoveries across the #cancerresearch continuum with unmatched customization, streamline workflows, and innovations that scale complex applications with confidence. Come say hi! 👋

We are excited to attend the Precision Medicine World Conference (#PMWC26) this year! Join us at booth #B722 to explore how IDT supports over 80% of the #MRDresearch market with high quality manufacturing, advanced technologies, and trusted partnerships. Learn more: pmwcintl.com

We’re excited to unveil IDT’s latest #NGS innovation roadmap—purpose-built to accelerate cancer breakthroughs and empower researchers working at the forefront of precision #oncologyresearch. 👏 Read more here: idtb.io/pa7j4h #cancerresearch #precisiononcology #precisionhealth

#MRD assessment and #MCED are transforming #cancercare strategies. Learn more about how IDT’s advanced #NGS solutions are powering the research behind this progress: idtb.io/xtkf2o #cancerresearch #oncologyresearch

Heading to #AGBT26 next week? Don’t miss the opportunity to see two innovative poster presentations showcasing how IDT overcomes genomic complexities with confidence and trusted expertise. Details are below! 🔗Learn more here: idtb.io/1y5me0

Our custom valentines are guaranteed to make your base pair blush.😊 Happy Valentine’s Day from all of us at IDT!💘

📣Attention #AGBT26 attendees! IDT President Ajay Gannerkote and CTO Steven Henck will be presenting on new products, practical strategies and real-world insights designed to accelerate your discovery and make your next breakthrough possible. 📅February 25 at 3:00 p.m. 🔗Learn more: idtb.io/1y5me0

In honor of International Women and Girls in Science Day, IDT's Laurie Kurihara reflects on what first sparked her interest in science, the challenges she has faced as a woman in the industry, and the advice she'd give to young women pursuing science careers:

The era of “using” #AIinscience is ending, and human–AI collaboration is here. IDT CTO Steven Henck shares insights from our #JPMWeek panel with Mithrl about trust, data, and the rise of the hybrid scientist in the AI era. Read the full article: www.linkedin.com/pulse/end-us...

Looking forward to a totally tubular time at #AGBT26!🤙 Meet with IDT trusted experts and learn how our NGS portfolio is powering discoveries across cancer research with unmatched customization, streamlined workflows, and innovations that scale complex applications with confidence. 🔗 idtb.io/1y5me0

What incredible news to welcome on #WorldCancerDay. We're delighted to see that Congress has passed legislation establishing a pathway for Medicare coverage of multi‑cancer early detection tests—a breakthrough that could expand access to cancer screenings and save countless lives: lnkd.in/gyPiznjX

When you're congratulated for exciting new data, which now means you need to do more experiments. 💀

Looking to accelerate your #infectiousdiseaseresearch? We offer both ready-to-use and custom solutions—from our PrimeTime™ Pathogen Research Panels to our custom amplicon NGS panels, we’re here to propel your research with flexibility, speed, and scalability. Start here: idtb.io/o9tw8t

IDT President Ajay Gannerkote discussed the importance of #MRDmonitoring and #MCED to the future of #cancercare on a panel at the annual #HLTHconference—take a look below. 👇 #cancerresearch #oncologyresearch #personalizedmedicine #precisionmedicine #HLTHevents

We’re having a blast at Festival of Genomics and Biodata in London! 🎡 Want to learn more about how our NGS tools can streamline your workflows and help you achieve accurate, reliable results? Join us at booth #143B—we’re excited to chat with you! 👋 #FOG2026 #FOG26 #NGS #nextgenerationsequencing

Imagine a world where #cancercare is so personalized that we can treat it on a cellular level. That’s where we’re heading with the power of MRD monitoring and MCED. Our experts and NGS solutions are accelerating the research behind this progress—learn more here: lnkd.in/eYe4cAmX

IDT President Ajay Gannerkote writes about how AI is accelerating the future of synbio—from designing gene-editing components with precision to predicting protein functions. However, as AI-enabled tools advance, so do the biosecurity challenges. Read more: www.ddw-online.com/how-ai-is-tr...

NEW eBOOK DROP! 📖 Our new expert guide will help you master FDA and EMA requirements, streamline your development process, and ensure compliant, ethical #CRISPRtherapeutics. Don’t miss your chance to get this free resource! Download here: idtb.io/fl3hkq #regulatory #CRISPR #CRISPRtherapies

ICYMI: We’re partnering with @ansabio.bsky.social to provide customers with access to long, #complexDNA, ranging from 100 bp to 50 kb! Take a look at how this collaboration has delivered value to Manos Papadakis, Senior Research Scientist, @dsmfirmenich.bsky.social. 👇 Read more: idtb.io/c2tiva

We’re delighted to return to Festival of Genomics and Biodata 2026! Join us at booth #143B to learn how our #NGS tools can streamline your workflows and help you achieve accurate, reliable results. Learn more here: hubs.la/Q03WbxXV0 #FOG2026 #FestivalofGenomics #NGStools

ICYMI: We’re not just expanding our footprint in Sunnyvale—we’re welcoming back a visionary leader. As part of this strategic move, Steven Henck returns to IDT as Chief Technology Officer! 👏🧬 Learn more: idtb.io/nkq0c5

#Cancercare is evolving, and #precisiononcology is leading the way. Learn how #MRD assessment and #MCED are transforming treatment strategies and how IDT’s advanced #NGSsolutions are powering the research behind this progress: idtb.io/xtkf2o #cancerresearch #oncologyresearch

It was a full house last night at our JPM event with Mithrl! Our panel explored some of the most pressing questions around #AI in biology. IDT's Steven Henck reminded us that AI won’t replace scientists—but scientists using AI will lead the way. “AI is not just a tool. It’s becoming a collaborator.”

New partnership announcement! 🤝 We’re proud to collaborate with @ansabio.bsky.social to provide our customers with access to long, complex #clonalDNA ranging from 100 bp to 50 kb. Read more here: idtb.io/xfs37g #SyntheticBiology #DNASynthesis #synbio #lifesciencesnews

Big news! 📍 We’re relocating our Redwood City site to Sunnyvale, California! Our new facility will feature state-of-the-art lab and office space designed to foster greater innovation, enhance R&D initiatives, and deepen collaboration opportunities with partners. 🔗Read more: idtb.io/nkq0c5

Let us power your infectious disease research! 💪 With a legacy of customization, agility and global expertise, you can trust in us to ensure your #qPCR and #NGS workflows are ready-built for current and emerging global health threats. Propel your research forward: idtb.io/o9tw8t

Cancer care is evolving, and #precisiononcology is leading the way. Learn how #MRD monitoring and #MCED are transforming treatment strategies and how IDT is delivering advanced #NGSsolutions that are precision-engineered to power the research behind this progress. 🔗Read our blog: idtb.io/yifp65

IDT’s Alt-R™ HDR Enhancer Protein🌟 Boost HDR efficiency without compromising genomic integrity and cell viability. This first-to-market protein enables precise editing of the gene—compatible with a variety of cell types (such as iPSC & HSBCs), nucleases, and donor templates: https://idtb.io/fov3yc

⏰It’s almost time for our Bay Area happy hour! Join us for an exclusive panel discussion on the future of biopharma and networking opportunities with IDT experts and leaders shaping the future of science. 🔗Claim your spot: luma.com/4nka1da9 #JPM26 #JPM2026

Multi-cancer early detection (MCED) and minimal residual disease (MRD) monitoring promise to detect cancer earlier, monitor treatment effectiveness more accurately, and ultimately improve patient outcomes. ✅ Read more from IDT President Ajay Gannerkote in GenomeWeb here: https://bit.ly/4b0IDtX